| Financial Year |
March 31 2023 |
| Monetary Funds |
4,434,237,012.08 |
| Held-for-trading Financial Assets |
113,329,642.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,156,667,859.85 |
| Advances to Suppliers |
116,468,255.29 |
| Other Receivables |
351,873,308.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
40,523,284.06 |
| Inventories |
1,717,907,089.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
206,697,335.83 |
| Other Current Assets |
216,902,668.09 |
| Total Current Assets |
8,314,083,171.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,137,049.72 |
| Investment Properties |
-- |
| Fixed Assetes |
4,128,539,739.60 |
| Under-construction Projects |
1,135,302,276.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,007,859,351.41 |
| R&D expenses |
-- |
| Goodwill |
325,461,480.95 |
| Long-Term Deferred and Prepaid Expenses |
129,731,586.68 |
| Deferred Income Tax Assets |
349,459,665.79 |
| Other Non-Current Assets |
35,446,969.49 |
| Sub-Total of Non-Current Assets |
7,969,525,767.45 |
| Total Assets |
16,283,608,938.83 |
| Short-Term Loans |
1,954,870,227.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,845,021.85 |
| Accounts Payable |
1,725,929,374.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
369,788,410.75 |
| Taxes Payable |
250,139,235.80 |
| Interest Payable |
-- |
| Dividend Payable |
1,537,032.02 |
| Other payables |
405,631,893.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
165,730,802.80 |
| Other Current Liabilities |
153,304,204.42 |
| Sub-Total of Current Liabilities |
6,462,117,266.06 |
| Long-term Loans |
8,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,382,790.20 |
| Deferred Income Tax Liabilities |
50,509,992.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
385,395,643.78 |
| Total Liabilities |
6,847,512,909.84 |
| Paid-In Capital(Or Share Stock) |
821,891,519.00 |
| Capital Surplus |
3,560,090,466.75 |
| Surplus Reserve |
428,398,491.82 |
| LESS:Treasury Stock |
41,884,303.55 |
| Undistributed Profits |
5,001,278,630.35 |
| Minority Stockholder's Interest |
178,592,685.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,257,503,343.97 |
| Owner's Equity（Stockholder's Equity） |
9,436,096,028.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,283,608,938.83 |
